4599 StemRIM Inc.ステムリムTSE Growth / Pharmaceuticals
0 posts
StemRIM Inc. (4599) at a glance
Prices are from Yahoo! Finance and may be delayed. Always check the latest price before trading.
StemRIM Inc. (4599) Stock Price History
StemRIM Inc. closed at ¥122 on Nov 20, 2026, −20.8% over 1 month, −56.0% over 1 year.
If you had invested ¥100,000 1 month ago, it would be worth ¥79,221 today (−20.8%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved −11.9%, while this stock moved −20.8%.
Last 10 Trading Days
| Date | Close | Change | % Change |
|---|---|---|---|
| Nov 20 (Fri) | ¥122 | −4 | −3.17% |
| Nov 18 (Wed) | ¥126 | +4 | +3.28% |
| Nov 17 (Tue) | ¥122 | +0 | +0.00% |
| Nov 16 (Mon) | ¥122 | +5 | +4.27% |
| Nov 13 (Fri) | ¥117 | −2 | −1.68% |
| Nov 12 (Thu) | ¥119 | +0 | +0.00% |
| Nov 10 (Tue) | ¥119 | +3 | +2.59% |
| Nov 9 (Mon) | ¥116 | +5 | +4.50% |
| Nov 6 (Fri) | ¥111 | −12 | −9.76% |
| Nov 5 (Thu) | ¥123 | −7 | −5.38% |
If you had invested ¥100,000 3 months ago, it would be worth ¥34,366 today (−65.6%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved −14.8%, while this stock moved −65.6%.
Last 10 Trading Days
| Date | Close | Change | % Change |
|---|---|---|---|
| Nov 20 (Fri) | ¥122 | −4 | −3.17% |
| Nov 18 (Wed) | ¥126 | +4 | +3.28% |
| Nov 17 (Tue) | ¥122 | +0 | +0.00% |
| Nov 16 (Mon) | ¥122 | +5 | +4.27% |
| Nov 13 (Fri) | ¥117 | −2 | −1.68% |
| Nov 12 (Thu) | ¥119 | +0 | +0.00% |
| Nov 10 (Tue) | ¥119 | +3 | +2.59% |
| Nov 9 (Mon) | ¥116 | +5 | +4.50% |
| Nov 6 (Fri) | ¥111 | −12 | −9.76% |
| Nov 5 (Thu) | ¥123 | −7 | −5.38% |
If you had invested ¥100,000 6 months ago, it would be worth ¥42,807 today (−57.2%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved −5.6%, while this stock moved −57.2%.
Monthly Closes
| Month | Month-End Close | Monthly % |
|---|---|---|
| Nov 2026 | ¥122 | −12.2% |
| Oct 2026 | ¥139 | −18.2% |
| Sep 2026 | ¥170 | −48.8% |
| Aug 2026 | ¥332 | +11.4% |
| Jul 2026 | ¥298 | −8.0% |
| Jun 2026 | ¥324 | +9.5% |
| May 2026 | ¥296 | −1.3% |
If you had invested ¥100,000 1 year ago, it would be worth ¥44,043 today (−56.0%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved +13.3%, while this stock moved −56.0%.
Monthly Closes
| Month | Month-End Close | Monthly % |
|---|---|---|
| Nov 2026 | ¥122 | −12.2% |
| Oct 2026 | ¥139 | −18.2% |
| Sep 2026 | ¥170 | −48.8% |
| Aug 2026 | ¥332 | +11.4% |
| Jul 2026 | ¥298 | −8.0% |
| Jun 2026 | ¥324 | +9.5% |
| May 2026 | ¥296 | −1.3% |
| Apr 2026 | ¥300 | +2.4% |
| Mar 2026 | ¥293 | −4.6% |
| Feb 2026 | ¥307 | +5.9% |
| Jan 2026 | ¥290 | +10.3% |
| Dec 2025 | ¥263 | −6.1% |
| Nov 2025 | ¥280 | ― |
If you had invested ¥100,000 3 years ago, it would be worth ¥17,889 today (−82.1%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved +67.8%, while this stock moved −82.1%.
Yearly Closes
| Year | Year-End Close | Yearly % |
|---|---|---|
| 2026 (YTD) | ¥122 | −53.6% |
| 2025 | ¥263 | ― |
If you had invested ¥100,000 5 years ago, it would be worth ¥22,385 today (−77.6%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved +96.3%, while this stock moved −77.6%.
Yearly Closes
| Year | Year-End Close | Yearly % |
|---|---|---|
| 2026 (YTD) | ¥122 | −53.6% |
| 2025 | ¥263 | ― |
If you had invested ¥100,000 in Aug 2019, it would be worth ¥12,829 today (−87.2%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved +159.4%, while this stock moved −87.2%.
Yearly Closes
| Year | Year-End Close | Yearly % |
|---|---|---|
| 2026 (YTD) | ¥122 | −53.6% |
| 2025 | ¥263 | −16.2% |
| 2024 | ¥314 | −45.7% |
| 2023 | ¥578 | −35.7% |
| 2022 | ¥899 | +2.0% |
| 2021 | ¥881 | +37.4% |
| 2020 | ¥641 | −30.3% |
| 2019 | ¥920 | ― |
Daily, weekly and monthly closes (Yahoo! Finance, split-adjusted, dividends excluded). "All" covers the range Yahoo provides (from Aug 2019). Please check the latest prices before trading.
StemRIM Inc. (4599) financial indicators
PER, ROE and dividend yield are based on company forecasts, calculated from earnings reports and the closing price after each trading day.
Key features of StemRIM Inc. (4599)
Business overview
The company is a drug developer researching "regeneration-inducing medicines". Instead of administering living cells, these drugs activate stem cells already in the patient's body to promote regeneration of damaged tissue, a new mechanism of action. It hopes they will work across a wide range of diseases, including central nervous system disorders such as stroke and ALS, cardiovascular disease such as heart attacks, intractable skin ulcers, chronic liver disease, bone and cartilage injuries and pulmonary fibrosis.
Summarized from the annual securities report (fiscal year ended July 2025) filed on EDINET.
Position within Pharmaceuticals (79 companies)
| PBR | 1.84x | Below the sector median of 1.86x (No. 38 from the lowest) |
|---|---|---|
| Market cap | ¥7.6 bn | No. 50 in the sector (largest first) |
Ranks among stocks in the same Tokyo Stock Exchange sector (33 sectors). PER and PBR of zero or below (losses, negative equity) are excluded and ranked from the lowest.
Price milestones
| 52-week high | ¥357 | 8/28 |
|---|---|---|
| 52-week low | ¥111 | 11/6 |
| Current position | 4.5% | Where the low is 0% and the high is 100% (close on 11/20: ¥122) |
| Year to date | -53.6% | No. 70 of 77 in the sector (best first) |
| 1 year | -56.0% |
Based on closing prices (adjusted for stock splits, excluding dividends).
Calculated as of 2026/11/20 17:30 JST. Updated every business day in the evening.
Recent disclosures (TDnet, in Japanese)
- 11/11 15:30譲渡制限付株式報酬としての新株式の発行に関するお知らせ
- 11/09 15:30再生誘導医薬レダセムチド(HMGB1断片ペプチド)の脂肪肝及び非アルコール性脂肪肝炎を適応症とした特許登録(オーストラリア)のお知らせ
- 11/09 15:30再生誘導医薬レダセムチド(HMGB1断片ペプチド)の軟骨疾患を適応症とした特許登録(イスラエル)のお知らせ
- 10/30 15:30事業計画及び成長可能性に関する事項
- 10/27 15:30公益財団法人財務会計基準機構への加入状況及び加入に関する考え方等に関するお知らせ
- 10/07 15:30栄養障害型表皮水疱症の根治治療を目的とした幹細胞遺伝子治療技術(開発コード:SR-GT1)の特許登録(米国)のお知らせ
- 09/25 15:30取締役候補者、監査役及び補欠監査役候補者の選任に関するお知らせ
- 09/25 15:30執行役員、従業員及び社外協力者に対するストック・オプションとしての新株予約権に関するお知らせ
- 09/25 15:30再生誘導医薬レダセムチド(HMGB1断片ペプチド)の軟骨疾患を適応症とした特許登録(韓国)のお知らせ
- 09/10 17:00当社取締役に対するストック・オプション(新株予約権)の発行内容確定に関するお知らせ
Show 4 more
- 09/10 17:00当社執行役員及び従業員に対するストック・オプション(新株予約権)の発行内容確定に関するお知らせ
- 09/09 16:00当社執行役員及び従業員に対するストック・オプション(新株予約権)の発行に関するお知らせ
- 09/09 16:002026年7月期 決算短信〔日本基準〕(非連結)
- 09/09 16:00当社取締役に対するストック・オプション(新株予約権)の発行に関するお知らせ
Filings from the past 12 months (14).
Posts
This board is shared with the Japanese and Chinese versions. Feel free to write in English, Chinese or Japanese.
No posts yet. Be the first to write something.
Write on the StemRIM Inc. board
More Japanese stocks in English
- Nomura High-yield J-REIT Index ETF459A
- BRANU Inc.460A
- Dai Nippon Toryo Company,Limited4611
- NIPPON PAINT HOLDINGS CO.,LTD.4612
- KANSAI PAINT CO.,LTD.4613
- SHINTO PAINT COMPANY,LIMITED4615
- KAWAKAMI PAINT MANUFACTURING CO.,LTD.4616
- Chugoku Marine Paints,Ltd.4617
- Nihon Tokushu Toryo Co.,Ltd.4619
- MAXIS Japan Equity High Dividend SMART 50 ETF461A
- FUJIKURA KASEI CO.,LTD.4620
- ASAHIPEN CORPORATION4623